An overview of iwNHL 2016 by Prof. Anas Younes
Highlights from EBMT 2016: Immunotherapy
Phase I trial results for nivolumab and pembrolizumab in lymphoma and multiple myeloma
Panel discussion on novel therapies and targets for lymphoma
John Gribben et al.
Immunotherapy for multiple myeloma: current research avenues